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Abstract
Ophthalmologists and researchers in ophthalmology understand what a rapidly evolving field
ophthalmology is, and that to conduct good research it is essential to use the latest and best
methods. In outcomes research, one modern initiative has been to conduct holistic measurement
of outcomes inclusive of the patient's point of view; patient-centred outcome. This, of course,
means including a questionnaire. However, the irony of trying to improve outcomes research by
being inclusive of many measures is that the researcher may not be expert in all measures used.
Certainly, few people conducting outcomes research in ophthalmology would claim to be
questionnaire experts. Most tend to be experts in their ophthalmic subspecialty and probably
simply choose a popular questionnaire that appears to fit their needs and think little more about it.
Perhaps, unlike our own field, we assume that the field of questionnaire research is relatively stable.
This is far from the case. The measurement of patient-centred outcomes with questionnaires is a
rapidly evolving field. Indeed, over the last few years a paradigm shift has occurred in patient-
centred measurement.
Text
Measurement of patient-centred health outcomes began
in the 1950s, and more than 70 measures of functional
status, 2 dozen generic quality of life instruments, and
hundreds of disease-specific measures now exist [1-4].
Much of this research has relied on the theory and meth-
ods of Classical Test Theory (CTT). Underpinning CTT is
simple scoring of responses to questionnaires; for multi-
category response scales this is usually summary scoring
where response categories are assigned ordinal numbers
which are summed across questions to arrive at a total
score. This score is assumed to represent measurement of
the underlying trait (e.g. quality of life). An alternative
approach is Item Response Theory (IRT) whereby items
and persons can be scaled according to a series of
responses to items. Implicit is that not only can people
have different ability, but that items can have different dif-
ficulty and both can be estimated. The foundations of IRT
were laid down in the 1920s, and great advances were
made after 1950, especially with the contribution of
Georg Rasch [5,6]. Rasch analysis is a special case of IRT
similar to a one-parameter model, but importantly, Rasch
models meet the conditions of non-interactive conjoint
structures so, unlike IRT models, they are valid measure-
ment models [7]. (See Massof's excellent background
paper for further discussion of these methods as applied
to ophthalmology [8]). It has only been in the last 25
years that Rasch analysis has been applied in studies of
health status. Early applications included mental health
and physical rehabilitation in the 1980s [9,10], including
low vision rehabilitation [11,12]. Through the 1990s, and
into the 21st century, Rasch analysis has penetrated many
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thalmology.
However, many popular ophthalmic questionnaires use
traditional summary scoring [13]. Summary scoring
assumes the value of each item represents equal difficulty
and therefore scores them equally. In addition, the ordi-
nal integer response scale used for each item assumes uni-
form changes between response categories. For example,
in a summary scored vision disability instrument such as
the 'Activities of Daily Vision Scale (ADVS)'[14], a
response of "a little difficulty" (score of 4) is used to rep-
resent twice the level of ability as "extreme difficulty"
(score of 2) which is similarly two times as good as "una-
ble to perform the activity due to vision" (score of 1) for
all items. This appears illogical and Rasch analysis has
been used to confirm that specific response category cali-
brations are required to provide a linear scale [15]. Simi-
larly, summary scoring assumes that all items are of equal
difficulty. For example, with the ADVS instrument an
answer of "a little difficulty" to the question regarding vis-
ual difficulties 'driving at night' scores the same as "a little
difficulty" with 'driving during the day'. Again, this is
illogical and Rasch analysis has been used to confirm that
subjects report that 'driving at night' is a more difficult
task than 'driving during the day'; Rasch analysis can pro-
vide the appropriate weighting for each item to enable lin-
ear measurement [15].
By resolving inequities in a scale arising from differential
item difficulty, Rasch analysis provides a self-evident ben-
efit in terms of accuracy of scoring. However, this process
also removes noise from the measurement which in turn
improves sensitivity to change and correlations with other
variables [16,17]. Clearly, these are important benefits for
outcomes research with implications for sample sizes etc.
The assumption of unidimensionality inherent in Rasch
analysis also provides unparalleled insight into the
dimensionality of a questionnaire. This can be used to
advantage in questionnaire development. Therefore,
beyond its simple application, Rasch analysis has been
used in three important ways in ophthalmology: the
development of new questionnaires, shortening or revis-
ing existing questionnaires, and test equating.
Across ophthalmology, a number of questionnaires have
been developed using Rasch analysis. The field of low
vision has led the way with the Veterans Affairs Low-
Vision Visual Functioning Questionnaire, the Melbourne
Low Vision ADL Index and the Visual Function Question-
naire [18-22]. Two Rasch scaled questionnaires have also
been developed for refractive outcomes: one for specta-
cles, contact lenses and refractive surgery (The Quality of
Life Impact of Refractive Correction, QIRC) and one for
contact lenses only (Contact lens Impact on Quality of
Life, CLIQ) [23-26]. While other sub-fields of ophthal-
mology are yet to gain questionnaires developed using
Rasch analysis, these are likely not far away as a recent
major review of quality of life in glaucoma called for the
development of a Rasch scaled glaucoma-specific visual
disability questionnaire [27].
Existing conventionally validated questionnaires can be
rescaled using Rasch analysis. In this way, summary scor-
ing can be converted to a truly linear scale using a simple
formula. This has occurred for cataract surgery outcomes
[28], refractive surgery outcomes [17], age-related macular
degeneration outcomes [29], low vision care [30], and the
measurement of ophthalmic pain [31,32]. Some of these
approaches have been to simply rescore an existing ques-
tionnaire, while others have taken the approach of com-
pletely re-engineering a questionnaire to optimize its
performance. The latter process takes advantage of the
insight into dimensionality of a questionnaire to refine
measurement and improve targeting of content to the
population. Notable examples of questionnaire re-engi-
neering are the Impact of Visual Impairment (IVI) for low
vision outcomes [33,34], the Visual Disability Assessment
(VDA) reinvented as the Cataract Outcomes Question-
naire [28,35], and The Visual Functioning 14 (VF-14) [36-
38]. Usually, re-engineering of questionnaires involves
removal of poorly fitting items to make a shorter ques-
tionnaire, although Velozo et al actually added items to
the VF-14 and yet were unable to completely satisfactorily
improve the instrument [36]. Rasch analysis has also been
used to simply confirm the performance of, or detect defi-
ciencies in questionnaires [39-42].
In ophthalmology, the most important patient-centred
outcome measure is visual disability. Visual disability is
the reason for performing cataract surgery, world wide the
most common operation performed, and visual disability
is a consequence of many ophthalmic diseases. Accord-
ingly, there are many visual disability questionnaires e.g.:
the Visual Activities Questionnaire (VAQ) [43], the Activ-
ities of Daily Vision Scale (ADVS) questionnaire [44], the
VF-14 [45], the VDA [35], the National-Eye Institute Vis-
ual Functioning Questionnaire (NEI-VFQ)[46] and the
Catquest questionnaire [47]. These questionnaires are
widely used in different part of the world, for instance
Catquest is widely used in Europe, the VF-14 in North
America, and the VDA in Australia. While these question-
naires all measure the same concept, and have many of
the same items, their scores cannot be simply compared.
However, Rasch analysis provides a mechanism to equate
scores from different questionnaires. Since all these ques-
tionnaires measure the same underlying trait, visual disa-
bility, they can all be modelled on the same latent
variable. Massof has made an important first step in
equating visual disability questionnaires implementingPage 2 of 4
(page number not for citation purposes)
BMC Ophthalmology 2006, 6:25 http://www.biomedcentral.com/1471-2415/6/25the ADVS, VAQ, VF-14 and the NEI-VFQ on a large popu-
lation, conducting Rasch analysis and providing equa-
tions for conversion of summary scores to Rasch scores
and conversion between questionnaires [48]. While Rasch
analysis is in itself fairly simple, its application is some-
what specialized. Massof's equations provide a mecha-
nism to gain the benefits of Rasch scaling without having
to perform Rasch analysis.
Today, the outcomes researcher is faced with many differ-
ent published questionnaires to choose from; some sum-
mary scored, others Rasch scaled. A major recent review by
De Boer et al has attempted to make sense of this choice
by systematically classifying questionnaires by the quality
of their development and validation [49]. Notably, de
Boer et al included Rasch scaling as a point of differentia-
tion. A logical extension of this would be to rate highest
questionnaires developed using Rasch analysis, followed
by those conventionally developed and re-engineered
using Rasch analysis and then those simply re-scored
using Rasch analysis. There seems to be little advantage in
using non-Rasch scaled questionnaires given this will
increase noise and therefore reduce statistical power.
Despite this, summary scored questionnaires remain pop-
ular [50], perhaps due to the simplicity of their scoring.
But, many questionnaire developers, and other research-
ers, provide simple Rasch scale conversion obviating the
need for questionnaire users to perform Rasch analysis
[22,23,48]. This simple step would have added significant
value to the paper by Owen et al published in this edition
of BMC Ophthalmology [50]. Hopefully, others will agree
that the time has come to abandon summary scoring. Lets
just hope that Max Planck's pessimism about scientific
change: "a new scientific truth does not triumph by convincing
its opponents and making them see the light, but rather because
its opponents eventually die, and a new generation grows up
that is familiar with it" does not hold true for the Rasch
analysis paradigm shift.
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